Bio-Techne to Present at Upcoming Investor Conferences

Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Wells Fargo Healthcare Conference on September 3 at 10:15 AM EDT, the Baird Global Healthcare Conference on September 9 at 9:05 AM EDT, and the Morgan Stanley Global Healthcare Conference on September 10 at 10:45 AM EDT.

Investors can access live webcasts of all presentations through Bio-Techne's Investor Relations website under the IR Calendar page.

News Market Reaction – TECH

-1.00%

21 alerts

-1.00% Session close to close

$8.37B Market Cap

0.6x Rel. Volume

In the Aug 27 session, TECH declined 1.00%, reflecting a mild negative market reaction. Our momentum scanner triggered 21 alerts that day, indicating elevated trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Aug. 27, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it will present at the following investor conferences:

2025 Wells Fargo Healthcare Conference
September 3, 2025
10:15 AM EDT

Baird 2025 Global Healthcare Conference
September 9, 2025
9:05 AM EDT

Morgan Stanley 23^rd Annual Global Healthcare Conference
September 10, 2025
10:45 AM EDT

A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: LinkedIn, X or YouTube.

Contact:  David Clair, Vice President, Investor Relations & Corporate Development
               david.clair@bio-techne.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302539292.html

SOURCE Bio-Techne Corporation

FAQ

When is Bio-Techne (TECH) presenting at the Wells Fargo Healthcare Conference 2025?

Bio-Techne will present at the Wells Fargo Healthcare Conference on September 3, 2025 at 10:15 AM EDT.

How can investors watch Bio-Techne's conference presentations in September 2025?

Investors can access live webcasts of all presentations through Bio-Techne's Investor Relations website at the IR Calendar page.

Which investor conferences will Bio-Techne (TECH) attend in September 2025?

Bio-Techne will present at three conferences: the Wells Fargo Healthcare Conference (Sept 3), Baird Global Healthcare Conference (Sept 9), and Morgan Stanley Global Healthcare Conference (Sept 10).

What time is Bio-Techne's presentation at the Morgan Stanley Healthcare Conference 2025?

Bio-Techne will present at the Morgan Stanley Global Healthcare Conference on September 10, 2025 at 10:45 AM EDT.